Literature DB >> 17706159

Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients.

Maria Rosaria Raspollini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17706159     DOI： 10.1007/s11912-007-0042-z

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  4 in total

1.  Sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Brian I Rini; Ronald M Bukowski; Brendan D Curti; Daniel J George; Gary R Hudes; Bruce G Redman; Kim A Margolin; Jaime R Merchan; George Wilding; Michelle S Ginsberg; Jennifer Bacik; Sindy T Kim; Charles M Baum; M Dror Michaelson
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Cyclooxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma.

Authors:  Maria Rosaria Raspollini; Gianni Amunni; Alessandro Villanucci; Gianna Baroni; Gian Luigi Taddei
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

3.  Sunitinib in advanced renal cell carcinoma: new treatment option?

Authors:  Ronald M Bukowski
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

4.  Impact of immune parameters on long-term survival in metastatic renal cell carcinoma.

Authors:  Frede Donskov; Hans von der Maase
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.